ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 518 out of 2888

$795K Total Retail Price of All Prescriptions

Rank: 368 out of 2888

412 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
AMLODIPINE BESYLATE 553 442 1 5
GABAPENTIN 507 400 2 13
LEVOTHYROXINE SODIUM 341 259 3 1
FUROSEMIDE 329 256 4 6
OMEPRAZOLE 272 184 5 7
SIMVASTATIN 269 223 6 2
METFORMIN HCL 262 172 7 8
HYDROCODONE-ACETAMINOPHEN 256 161 S3 8 4
METOPROLOL TARTRATE 251 185 9 10
LISINOPRIL 239 183 10 3
PANTOPRAZOLE SODIUM 177 120 11 33
HYDROCHLOROTHIAZIDE 169 133 12 15
ATORVASTATIN CALCIUM 156 122 13 9
POTASSIUM CHLORIDE 154 133 14 14
WARFARIN SODIUM 151 96 15 22
METOPROLOL SUCCINATE 146 122 16 11
SINGULAIR 133 100 17 85
CLONIDINE HCL 123 88 18 39
CALCITONIN-SALMON 118 101 19 284
ZETIA 115 104 20 81
TAMSULOSIN HCL 103 82 21 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 71 22 28
NEXIUM 97 73 22 19
GLIMEPIRIDE 93 74 24 36
TRAMADOL HCL 93 77 24 16
PRAVASTATIN SODIUM 90 72 26 12
ZOLPIDEM TARTRATE 90 55 26 17
JANUVIA 89 55 28 48
AMLODIPINE BESYLATE-BENAZEPRIL 88 67 29 67
GLIPIZIDE 85 77 30 50
ISOSORBIDE MONONITRATE ER 82 78 31 51
BENICAR HCT 78 55 32 181
DIOVAN HCT 72 60 33 61
SERTRALINE HCL 72 52 33 27
MELOXICAM 72 57 33 31
MONTELUKAST SODIUM 68 43 36 153
LYRICA 67 34 37 69
TRAZODONE HCL 66 54 38 43
CRESTOR 66 46 38 20
CEFUROXIME 63 51 40 130
DIGOXIN 63 63 40 55
NAMENDA 62 62 42 34
LOVASTATIN 60 52 43 41
ESCITALOPRAM OXALATE 59 38 44 62
LANTUS 58 46 45 45
LOSARTAN POTASSIUM 57 41 46 18
POLYETHYLENE GLYCOL 3350 54 30 47 93
LEVEMIR FLEXPEN 51 37 48 156
FLUOXETINE HCL 50 33 49 83
RAMIPRIL 50 41 49 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.